Analyst Ratings for Tenet Healthcare (THC) [Buys]
THC Rating Summary
THC Price Target Summary
- Highest: $55.00 (Deutsche Bank)
- Lowest: $5.00 (BMO Capital)
- Average: $28.67
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$28.67 (-35%)
Avg. $ Target:
$28.67 (-35%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/6/2013 | Deutsche Bank | Upgrade | Buy (Hold) |
55.00 (49.00) |
44.37 | 44.11 | -0.59% | Details |
| 4/29/2013 | Baird | Upgrade | Outperform (Neutral) |
N/A (N/A) |
41.16 | 44.11 | 7.17% | Details |
| 4/29/2013 | UBS | Upgrade | Buy (Neutral) |
N/A (N/A) |
41.16 | 44.11 | 7.17% | Details |
| 3/15/2013 | Ameriprise Financial | New Coverage | Buy (N/A) |
N/A (N/A) |
44.96 | 44.11 | -1.89% | Details |
| 3/8/2013 | CRT Capital | Upgrade | Buy (Fairly Valued) |
51.00 (N/A) |
41.76 | 44.11 | 5.63% | Details |
| 1/24/2013 | Raymond James | Upgrade | Outperform (Market Perform) |
45.00 (N/A) |
37.76 | 44.11 | 16.82% | Details |
| 1/11/2013 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
33.16 | 44.11 | 33.02% | Details |
| 1/3/2013 | Imperial Capital | Upgrade | Outperform (In-Line) |
40.00 (20.00) |
33.39 | 44.11 | 32.11% | Details |
| 12/18/2012 | JPMorgan | New Coverage | Overweight (N/A) |
41.00 (N/A) |
31.18 | 44.11 | 41.47% | Details |
| 6/29/2012 | Wells Fargo | Upgrade | Outperform (Market Perform) |
8.00 (N/A) |
5.25 | 44.11 | 740.19% | Details |
| 6/11/2012 | Citi | Upgrade | Buy (Sell) |
N/A (N/A) |
4.68 | 44.11 | 842.52% | Details |
| 6/30/2011 | Barclays | New Coverage | Overweight (N/A) |
N/A (N/A) |
6.19 | 44.11 | 612.6% | Details |
| 4/18/2011 | Soleil Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
6.66 | 44.11 | 562.31% | Details |
| 4/14/2011 | Jefferies » Updated 3/15/2012 |
New Coverage | Buy (N/A) |
6.50 (N/A) |
6.54 | 44.11 | 574.46% | Details |
